From antibody discovery to vaccine trials, your support is driving progress.
Fueled by your donation, research to understand the coronavirus and end the pandemic is happening at a scale and speed that none of us could have imagined a year ago. With your help, we opened a unique clinical research center to test therapies with the potential to stop COVID-19 before symptoms become debilitating or deadly. We are leading large-scale vaccine trials, isolating antibodies that neutralize the virus, and decoding the immune system’s response to coronavirus infection. Thanks to you, we are applying 45 years of expertise to solve a completely new problem — and we are making tangible progress.
Your belief in science — and your support of our work — makes all this possible. We are grateful, and we're proud to share how your generosity is helping to stop the pandemic.
Our researchers are playing a leading role in the international scientific response to the pandemic: exploring how the virus could mutate to escape detection by the immune system, creating complex computer models to understand viral transmission and super-spreading events, assessing the impact of COVID-19 on patients with cancer and underserved populations, and more. We’re also leading a campaign to ensure groups that face the highest risk of severe infection and death from COVID-19 are equitably represented in vaccine trials.
Your investment in the COVID-19 Research Fund has enabled scientists across Fred Hutch to move at record speed to tackle formidable challenges from many angles. Highlights include:
Your gift makes it possible to test outside-the-box ideas that are not yet ready for foundation or government funding. Donor-funded pilot awards allow scientists to generate the proof of concept they need to attract larger grants — and they are critical to jump-starting the most innovative projects. Thanks to you, the investigators listed below have received donor-funded COVID-19 pilot awards.
Research Associate, Vaccine and Infectious Diseases Division
Dr. Boonyaratanakornkit in the Taylor Lab is investigating how cells that have previously produced antibodies in response to common cold-causing coronaviruses influence infection by the pandemic-causing SARS-CoV-2 virus. His goal is to design 2-for-1 strategies that can protect people from both types of coronaviruses.
Assistant Professor, Clinical Research Division
Dr. Dey’s project is a “fail fast” study of whether it might be possible to target the microbiome to help patients recover more quickly or reduce the virus's chance of spreading through fecal transmission.
Assistant Professor, Human Biology Division
Dr. Gujral is employing new machine-learning methods to learn how the coronavirus causes immune cells to trigger “cytokine storms,” the cause of respiratory failure in severe cases in COVID-19, and to pinpoint potential treatments.
Assistant Professor, Public Health Sciences Division
Dr. Ko is leveraging her long-standing research partnerships with community-based organizations to evaluate the impact of COVID-19 on their ability to deliver lifeline services to older adults in the Asian American and Pacific Islander community. This project, which aims to inform strategies to improve health equity, is funded by the Vadon Foundation.
Principal Staff Scientist, Vaccine and Infectious Disease Division
Dr. Kublin’s team is studying microbes in the gut and respiratory tract of COVID-19 patients to look for a correlation between patients’ microbiomes and their clinical outcomes.
We’ve been amazed and impressed by the inventive ways people are using their unique skills and interests to work fuel COVID-19 research — all while sheltering at home. Here are a few examples: